Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.840
+0.140 (8.24%)
At close: Oct 2, 2025, 4:00 PM EDT
1.880
+0.040 (2.17%)
After-hours: Oct 2, 2025, 7:51 PM EDT

Propanc Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
2448010-
Upgrade
Market Cap Growth
-11514.72%-25.62%26.73%--
Upgrade
Enterprise Value
2449111-
Upgrade
Last Close Price
1.704.1574.858083.83220059.883095808.38
Upgrade
PB Ratio
2.843.47-0.11-0.18-0.15-
Upgrade
P/TBV Ratio
1.613.47----
Upgrade
Debt / Equity Ratio
0.120.12-0.25-0.17-0.34-0.22
Upgrade
Quick Ratio
0.000.000.010.000.000.00
Upgrade
Current Ratio
1.501.500.010.010.010.00
Upgrade
Return on Equity (ROE)
-1163.67%-1163.67%----
Upgrade
Return on Assets (ROA)
-363.36%-363.36%-1447.01%-1564.19%-2626.42%-2029.40%
Upgrade
Return on Capital (ROIC)
-559.26%-559.26%----
Upgrade
Earnings Yield
-262.91%-122.28%-438.79%-476.99%-603.95%-
Upgrade
FCF Yield
-1.81%-0.84%-225.39%-198.15%-326.34%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.